News & Events

The Maryland Stem Cell Research (MSCRF) Commission is pleased to announce over $14.1 million in grant awards to promote innovative research that will strengthen and advance stem cell treatments and technologies in Maryland. This is the largest amount awarded to Maryland-based institutions and

39 scientists from Maryland-based research institutions and companies will be receiving awards from this round of funding to advance research addressing an array of medical conditions, including cancer, eye, heart, bone, blood, digestive, and central nervous system diseases. Awardees include

Rise Therapeutics, based in Rockville, Md., is a clinical-stage biotechnology company focused on developing innovative treatments for devastating diseases. Rise has developed the Tripartite X drug delivery platform that leverages synthetic biology medicine to enable safe and effective oral delivery

Novel Microdevices, based in Baltimore, Md., is a woman-owned medical device company, working to revolutionize clinical diagnostics. Through this effort, the company has developed the Novel Dx device, a cost-effective, portable, rapid, and easy-to-use testing solution. The company is challenging the